N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
about
Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatinMetabolomics reveals the metabolic map of procainamide in humans and mice.DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cellsWill DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus.
P2860
N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
@en
N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
@nl
type
label
N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
@en
N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
@nl
prefLabel
N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
@en
N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
@nl
P2093
P356
P1476
N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
@en
P2093
Cornacchia E
Richardson B
Strahler J
P2860
P304
P356
10.1002/ART.1780310809
P577
1988-08-01T00:00:00Z